ArticleScientific reports2025
Celiac disease in children with focus on symptoms and quality of life.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07436884 (Dieta Sin Gluten Equilibrada y Segura), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Dieta Sin Gluten Equilibrada y Segura: Estudio De Biomarcadores y De Los Factores Determinantes Para Alcanzar El Equilibrio Nutricional y La Ausencia de Síntomas
Who cites it
2 citing papers in PubMed.
- Personality Traits Are Associated with Dietary Behaviors and Psychosocial Outcomes in Adolescents with Celiac Disease: A Cross-Sectional Study.Digestive diseases and sciences · 2026Article
- A model for predicting celiac disease among undiagnosed subjects established with data from the HUNT4 study.BMC gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The treatment for celiac disease (CD) consist of adhering to a gluten-free diet (GFD). Studies have reported that an appropriate and close nutritional assessment would be beneficial in improving symptoms and quality of life (QoL). This study investigated the effect of a nutritional intervention on the evolution of gastrointestinal (GI) and extraintestinal (EI) symptoms in children newly diagnosed with CD, and its association with QoL. 46 children who had recently been diagnosed with CD were followed up on three occasions during the year: at the time of diagnosis, and after 3 and 12 months (vt0, vt3 and vt12). Participants completed questionnaires on GI- and an EI-symptom, QoL and diet. Recovery was assessed based on clinical improvement and serological response. FODMAP consumption was analysed as a possible cause of symptoms. All patients received dietary advice and face-to-face follow-up. Although following a GFD is beneficial for symptom remission, recovery varies between patients. However, following a GFD is not sufficient to achieve a good QoL, with overall scores suggesting that participants have a poor QoL. Their parents/carers also have this perception. FODMAP consumption cannot be associated with a reduction in symptoms. Follow-up and nutritional education are important for improving GI and EI symptoms. However, more effort is needed to improve QoL in children with CD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.